UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Werner Enterprises
WERN
$2.18B
| $2.93M | ﹤0.01% |
111,192
-118,561
| -52% | -$3.33M |
|
1602
PureCycle Technologies
PCT
$1.52B
| $2.92M | ﹤0.01% |
221,946
-231,658
| -51% | -$3.22M |
|
1603
Leggett & Platt
LEG
$1.31B
| $2.91M | ﹤0.01% |
327,839
-280,794
| -46% | -$2.68M |
|
|
PENG
1604
Penguin Solutions Inc
PENG
$2.93B
| $2.91M | ﹤0.01% |
110,743
-69,762
| -39% | -$1.71M |
|
1605
Integra LifeSciences
IART
$1.35B
| $2.91M | ﹤0.01% |
202,956
-105,183
| -34% | -$1.44M |
|
1606
Dyne Therapeutics
DYN
$4.96B
| $2.9M | ﹤0.01% |
229,430
-64,214
| -22% | -$732K |
|
|
VRNT
1607
DELISTED
Verint Systems
VRNT
| $2.9M | ﹤0.01% |
143,300
-1,388,780
| -91% | -$28.6M |
|
1608
LeMaitre Vascular
LMAT
$1.88B
| $2.89M | ﹤0.01% |
32,997
-23,372
| -41% | -$2.09M |
|
1609
Lakeland Financial Corp
LKFN
$1.54B
| $2.87M | ﹤0.01% |
44,627
-26,928
| -38% | -$1.75M |
|
1610
MillerKnoll
MLKN
$1.63B
| $2.86M | ﹤0.01% |
161,349
-108,610
| -40% | -$2.2M |
|
1611
ACV Auctions
ACVA
$1.27B
| $2.86M | ﹤0.01% |
288,443
-184,877
| -39% | -$2.37M |
|
|
DVAX
1612
DELISTED
Dynavax Technologies
DVAX
| $2.85M | ﹤0.01% |
287,185
-205,540
| -42% | -$2.14M |
|
1613
NextNav
NN
$2.41B
| $2.85M | ﹤0.01% |
199,350
-61,346
| -24% | -$968K |
|
1614
Encore Capital Group
ECPG
$1.99B
| $2.84M | ﹤0.01% |
68,157
-33,448
| -33% | -$1.37M |
|
1615
Albany International
AIN
$1.78B
| $2.84M | ﹤0.01% |
53,367
-35,622
| -40% | -$2.26M |
|
1616
ACM Research
ACMR
$5.53B
| $2.84M | ﹤0.01% |
72,667
-469,070
| -87% | -$13.9M |
|
1617
REX American Resources
REX
$1.42B
| $2.82M | ﹤0.01% |
91,970
-72,954
| -44% | -$2.08M |
|
1618
DXP Enterprises
DXPE
$3.02B
| $2.81M | ﹤0.01% |
23,611
-17,780
| -43% | -$1.99M |
|
|
B
1619
Barrick Mining
B
$67.4B
| $2.79M | ﹤0.01% |
85,193
-1,521,077
| -95% | -$38.5M |
|
1620
Hilltop Holdings
HTH
$2.25B
| $2.79M | ﹤0.01% |
83,346
-60,182
| -42% | -$1.96M |
|
1621
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$964M
| $2.78M | ﹤0.01% |
101,633
+21,503
| +27% | +$452K |
|
|
CRCL
1622
Circle Internet Group
CRCL
$18.1B
| $2.78M | ﹤0.01% |
20,965
+20,250
| +2,832% | +$3.2M |
|
1623
Unitil
UTL
$982M
| $2.74M | ﹤0.01% |
57,164
-32,018
| -36% | -$1.56M |
|
1624
Celldex Therapeutics
CLDX
$3.48B
| $2.73M | ﹤0.01% |
105,478
-108,368
| -51% | -$2.51M |
|
1625
NeoGenomics
NEO
$2.13B
| $2.73M | ﹤0.01% |
353,258
-228,529
| -39% | -$1.6M |
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.